CTI BIOPHARMA CORP Quarterly Entity Common Stock, Shares Outstanding from Q2 2010 to Q1 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cti Biopharma Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2010 to Q1 2023.
  • Cti Biopharma Corp Entity Common Stock, Shares Outstanding for the quarter ending May 4, 2023 was 132M shares, a 32% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 132M +32M +32% May 4, 2023 10-Q 2023-05-15
Q3 2022 127M +30.2M +31.2% Oct 31, 2022 10-Q 2022-11-07
Q2 2022 114M +21.1M +22.6% Aug 1, 2022 10-Q 2022-08-08
Q1 2022 99.9M +23.2M +30.3% Mar 17, 2022 10-K 2022-03-31
Q3 2021 96.7M +22.9M +31.1% Oct 28, 2021 10-Q 2021-11-12
Q2 2021 93.3M +19.6M +26.6% Jul 29, 2021 10-Q 2021-08-05
Q1 2021 76.7M +3.01M +4.08% Mar 10, 2021 10-K 2021-03-17
Q3 2020 73.8M +15.8M +27.2% Nov 3, 2020 10-Q 2020-11-10
Q2 2020 73.7M +15.7M +27.1% Jul 30, 2020 10-Q 2020-08-07
Q1 2020 73.7M +15.7M +27.1% Mar 6, 2020 10-K 2020-03-13
Q3 2019 58M -9.84K -0.02% Oct 24, 2019 10-Q 2019-11-04
Q2 2019 58M -10.2K -0.02% Jul 25, 2019 10-Q 2019-08-01
Q1 2019 58M +2.09K +0% Apr 25, 2019 10-Q 2019-05-02
Q3 2018 58M +15M +35% Oct 25, 2018 10-Q 2018-11-01
Q2 2018 58M +15M +34.9% Jul 26, 2018 10-Q 2018-08-03
Q1 2018 58M +29.8M +105% Apr 26, 2018 10-Q 2018-05-03
Q3 2017 43M -239M -84.8% Oct 30, 2017 10-Q 2017-11-07
Q2 2017 43M -240M -84.8% Jul 27, 2017 10-Q 2017-08-04
Q1 2017 28.2M -255M -90% Apr 26, 2017 10-Q 2017-05-03
Q3 2016 282M +50.7M +21.9% Oct 27, 2016 10-Q 2016-11-08
Q2 2016 283M +102M +56.5% Jul 28, 2016 10-Q 2016-08-04
Q1 2016 283M +103M +57% May 3, 2016 10-Q 2016-05-10
Q4 2015 281M Feb 10, 2016 10-K 2016-02-17
Q3 2015 232M +81.6M +54.4% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 181M +30.7M +20.5% Jul 30, 2015 10-Q 2015-08-06
Q1 2015 180M +30.4M +20.3% Mar 5, 2015 10-K 2015-03-12
Q3 2014 150M +20.2M +15.6% Oct 24, 2014 10-Q 2014-10-31
Q2 2014 150M +35.2M +30.6% Jul 29, 2014 10-Q 2014-08-04
Q1 2014 150M +37.2M +33% Apr 23, 2014 10-Q 2014-04-29
Q3 2013 130M +32.9M +33.9% Oct 25, 2013 10-Q 2013-10-30
Q2 2013 115M -169M -59.5% Jul 26, 2013 10-Q 2013-07-31
Q1 2013 113M -115M -50.5% Apr 26, 2013 10-Q 2013-05-02
Q3 2012 97M -95.8M -49.7% Oct 25, 2012 10-Q 2012-11-01
Q2 2012 283M +90.5M +46.9% Jul 30, 2012 10-Q 2012-08-02
Q1 2012 228M Apr 13, 2012 10-Q 2012-04-20
Q3 2011 193M -622M -76.3% Oct 21, 2011 10-Q 2011-10-25
Q2 2011 193M -566M -74.6% Jul 22, 2011 10-Q 2011-07-28
Q3 2010 815M Oct 22, 2010 10-Q 2010-10-28
Q2 2010 758M Jul 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.